Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Ownership  |  Insiders

Stock Quote Today & Recent News Aeon Biopharma Inc AEON

Healthcare Biotechnology
AEON Biopharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing its botulinum toxin complex, ABP-450 (prabotulinumtoxinA) injection or ABP-450, for debilitating medical conditions, with an initial focus on the neuroscience market. ABP-450 is a 2-chain polypeptide, a heavy chain joined by a bond to a light chain. ABP-450 interferes with nerve impulses by... see more

Current News (NYSEAM:AEON)

AEON Biopharma Reports Third Quarter 2025 Results, Including Positive ABP-450 Biosimilarity Data and Strategic Positioning for Continued Growth

GlobeNewswire 4 days ago

AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711

GlobeNewswire May 23, 2025

AEON Biopharma to Present at the Aegis Capital Corp. Virtual Conference 2025

GlobeNewswire May 19, 2025

AEON Biopharma Reports First Quarter 2025 Financial Results and Provides Corporate Update

GlobeNewswire May 14, 2025

AEON Biopharma Announces NYSE American Acceptance of Plan to Regain Listing Compliance

GlobeNewswire April 25, 2025

AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711

GlobeNewswire April 21, 2025

AEON Biopharma Appoints Industry Veteran Rob Bancroft as Chief Executive Officer

GlobeNewswire April 21, 2025

AEON Biopharma Announces CEO Transition

GlobeNewswire March 27, 2025

AEON Biopharma Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

GlobeNewswire March 24, 2025
View More News ››

Opinion & Analysis (NYSEAM:AEON)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NYSEAM:AEON)

AEON.....LoL ...I'm back after buying that dip ; )

Now show me the money Mr. M
Iseneschal - March 10, 2025

AEON....TBH I still think there's more to come but....

I always like to leave some for the next guy ; ) Good Luck to all  Cheers !
Iseneschal - March 10, 2025

AEON....sold all into that rip to N.H.O.D

Cheers to us Bulls
Iseneschal - March 10, 2025

AEON.....told ya...Volume & Price Action

Best indicators going ; ) N.H.O.D ..... $1.30 There's more .... I think ; )
Iseneschal - March 10, 2025

AEON.....sooner or later she's going to rip

JMHO Now at $1.18 magnet
Iseneschal - March 10, 2025

AEON....LoL...nice rug pull...total BS

Wait for the big move 
Iseneschal - March 10, 2025
View more Bullboard ››

Tidal Care Inc.

Tidal Care Inc.

Tidal Care aims to be a high-compliance supplier of finished, formulated Psilocybin- and MDMA-based drug products to the ...
View More »